Statera Biopharma Financials

We advise to exercise Statera Biopharma fundamental analysis to find out if markets are presently mispricing the firm. In other words this technique allows you to confirm available indicators of Statera Biopharma as well as the relationship between them. We were able to analyze twenty-nine available drivers for Statera Biopharma, which can be compared to its competition.
  
Please note, the presentation of Statera Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Statera Biopharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Statera Biopharma's management manipulating its earnings.

Statera Biopharma Stock Summary

Statera Biopharma competes with NeuroSense Therapeutics, Acrivon Therapeutics,, Alector, Aadi Bioscience, and Keros Therapeutics. Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropeniaanemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the bodys immune system and restore homeostasis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 46 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS8575611046
CUSIP185860202 185860103 857561104 23284M100
LocationColorado; U.S.A
Business Address4333 Corbett Drive,
SectorHealthcare
IndustryBiotechnology
BenchmarkDow Jones Industrial
Websitewww.staterabiopharma.com
Phone888 613 8802
CurrencyUSD - US Dollar

Statera Biopharma Key Financial Ratios

Statera Biopharma's financial ratios allow both analysts and investors to convert raw data from Statera Biopharma's financial statements into concise, actionable information that can be used to evaluate the performance of Statera Biopharma over time and compare it to other companies across industries.

Statera Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Statera Biopharma's current stock value. Our valuation model uses many indicators to compare Statera Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Statera Biopharma competition to find correlations between indicators driving Statera Biopharma's intrinsic value. More Info.
Statera Biopharma is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Statera Biopharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Statera Biopharma's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Statera Biopharma Thematic Clasifications

Statera Biopharma is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
BiotechView
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in Statera Pink Sheet

If you are still planning to invest in Statera Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Statera Biopharma's history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum